Obesity, estrone, and coronary artery disease in postmenopausal women

Maturitas

Volumn 59, Issue 3, 2008, Pages 242-248

  Silva, T C B F ^a   Barrett Connor, E ^b   Ramires, J A F ^a   Mansur, A P ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Coronary artery disease; Estrogen; Estrone; Mortality; Obesity; Postmenopause

Indexed keywords

C REACTIVE PROTEIN; ESTRONE; GLUCOSE; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; ESTRONE BLOOD LEVEL; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MORTALITY; OBESITY; POSTMENOPAUSE; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; AGED, 80 AND OVER; BODY MASS INDEX; CORONARY ARTERY DISEASE; ESTRONE; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; LONGITUDINAL STUDIES; MIDDLE AGED; OBESITY; POSTMENOPAUSE; RISK FACTORS;

EID: 43049147552     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2008.01.008     Document Type: Article

References (33)

1. Mansur A.P., Favarato D., Souza M.F.M., et al. Tendência do risco de morte por doenças circulatórias no Brasil de 1979 a 1996. Arq Bras Cardiol 76 (2001) 497-510
2. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 340 (1999) 115-126
3. Kuulasmaa K., Tunstall-Pedoe H., Dobson A., et al. Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations. Lancet 355 (2000) 675-687
4. Stangl V., Baumann G., and Stangl K. Coronary atherogenic risk factors in women. Eur Heart J 23 (2002) 1738-1752
5. Gruber C.J., Tschugguel W., Schneeberger C., and Huber J.C. Production and actions of estrogens. N Engl J Med 346 (2002) 340-352
6. Meza-Munoz D.E., Fajardo M.E., Perez-Luque E.L., and Malacara J.M. Factors associated with estrogen receptors-alpha (ER-alpha) and -beta (ER-beta) and progesterone receptor abundance in obese and non obese pre- and postmenopausal women. Steroids 71 (2006) 498-503
7. Brown L., Hoong I., and Doggrell A.S. The heart as a target for oestrogens. Heart Lung Circ 9 (2000) 113-125
8. Mendelsohn M.E. Protective effects of estrogen on the cardiovascular system. Am J Cardiol 89 (2002) 12E-18E
9. Lerner D.J., and Kannel W.B. Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am Heart J 111 (1986) 383-390
10. Kamat A., Hinshelwood M.M., Murry B.A., and Mendelson C.R. Mechanisms in tissue-specific regulation of estrogen biosynthesis in humans. Trends Endocrinol Metab 13 (2002) 122-128
11. Puche C., Jose M., Cabero A., and Meseguer A. Expression and enzymatic activity of the P450c17 gene in human adipose tissue. Eur J Endocrinol 146 (2002) 223-229
12. Lukanova A., Lundin E., Zeleniuch-Jacquotte A., et al. Body mass index, circulating levels of sex-steroid hormones, IGF-I and IGF-binding protein-3: a cross-sectional study in healthy women. Eur J Endocrinol 150 (2004) 161-171
13. Flegal K.M., Graubard B.I., Williamson D.F., and Gail M.H. Excess deaths associated with underweight, overweight, and obesity. JAMA 293 (2005) 1861-1867
14. Romero-Corral A., Montori V.M., Somers V.K., et al. Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet 368 (2006) 666-678
15. Lakka H.M., Laaksonen D.E., Lakka T.A., et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288 (2002) 2709-2716
16. Mosca L., Barret-Connor E., Wenger N.K., et al. Design and methods of the Raloxifene Use for The Heart (RUTH) study. Am J Cardiol 88 (2001) 392-395
17. American Diabetes Association: diagnosis and classification of Diabetes Mellitus 2006. Diabetes Care 29 Suppl. S (2006) S43-S48
18. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. JAMA 289 (2003) 2560-2572
19. III Diretrizes Brasileiras Sobre Dislipidemias e Diretriz de Prevenção da Aterosclerose do Departamento de Aterosclerose da Sociedade Brasileira de Cardiologia. Arq Bras Cardiol 77 (2001) 4-8
20. World Health Organization. Guidelines for the conduct of the tobacco smoking surveys of the general population: report of a meeting. Geneva; 1992 (N/WHO/SMO/83.4).
21. Obesity: preventing and managing the global epidemic. Report of a WHO Consultation Technical Report Series no. 894. Geneva: World Health Organization; 2000.
22. Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifugation. Clin Chem 18 (1972) 499-509
23. http://www.cdc.gov/nchs/products/pubs/pubd/hestats/3and4/overweight.htm (assessed in June 15, 2007).
24. Bender R., Zeeb H., Schwarz M., Jockel K.H., and Berger M. Causes of death in obesity: relevant increase in cardiovascular but not in all-cancer mortality. J Clin Epidemiol 59 (2006) 1064-1071
25. McGee D.L., et al. Body mass index and mortality: a meta-analysis based on person-level data from twenty-six observational studies. Ann Epidemiol. 15 (2005) 87-97
26. Gregg E.W., Cheng Y.J., Cadwell B.L., et al. Secular trends in cardiovascular disease risk factors according to body mass index in US adults. JAMA 293 (2005) 1868-1874
27. Ridker P.M., Hennekens C.H., Buring J.E., and Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342 (2000) 836-843
28. Yudkin J.S., Stehouwer C.D., Emeis J.J., and Coppack S.W. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?. Arterioscler Thromb Vasc Biol 19 (1999) 972-978
29. Castracane V.D., Kraemer G.R., Ogden B.W., and Kraemer R.R. Interrelationships of serum estradiol, estrone, and estrone sulfate, adiposity, biochemical bone markers, and leptin in postmenopausal women. Maturitas 53 (2006) 217-225
30. Mudali S., et al. Endogenous postmenopausal hormones and serum lipids: the atherosclerosis risk in communities study. J Clin Endocrinol Metab 90 (2005) 1202-1209
31. Simon J.A., Hsia J., Cauley J.A., et al. Postmenopausal hormone therapy and risk of stroke: The Heart and Estrogen-progestin Replacement Study (HERS). Circulation 103 (2001) 638-642
32. Rossouw J.E., et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 288 (2002) 321-333
33. Wu J., Oka J., Higuchi M., et al. Cooperative effects of isoflavones and exercise on bone and lipid metabolism in postmenopausal Japanese women: a randomized placebo-controlled trial. Metabolism 55 (2006) 423-433